Pharmaceuticals in Canada

Date: September 26, 2016
Pages: 36
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P4269987287EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Canada
SUMMARY

Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Canada
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Canada
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Canada pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Canada pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Canada pharmaceuticals market by value in 2015?
  • What will be the size of the Canada pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Canada pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Canada's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Canadian pharmaceuticals market had total revenues of $19.2bn in 2015, representing a compound annual growth rate (CAGR) of 6.2% between 2011 and 2015.

Notably, growth in drug spending in Canada has slowed in recent years and is being outpaced by spending on hospitals and physicians. This is in some ways similar to other trends seen around the world as many countries are trying to cut down on the spending on actual drugs but usually also healthcare spending in general.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 10.5% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $31.7bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Apotex, Inc.
Johnson and Johnson
Merck and Co., Inc.
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Canada pharmaceuticals market value: $ billion, 2011-15
Table 2: Canada pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Canada pharmaceuticals market share: % share, by value, 2015
Table 4: Canada pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Apotex, Inc.: key facts
Table 6: Johnson and Johnson: key facts
Table 7: Johnson and Johnson: key financials ($)
Table 8: Johnson and Johnson: key financial ratios
Table 9: Merck and Co., Inc.: key facts
Table 10: Merck and Co., Inc.: key financials ($)
Table 11: Merck and Co., Inc.: key financial ratios
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: key financials ($)
Table 14: Pfizer Inc.: key financial ratios
Table 15: Canada size of population (million), 2011-15
Table 16: Canada gdp (constant 2005 prices, $ billion), 2011-15
Table 17: Canada gdp (current prices, $ billion), 2011-15
Table 18: Canada inflation, 2011-15
Table 19: Canada consumer price index (absolute), 2011-15
Table 20: Canada exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Canada pharmaceuticals market value: $ billion, 2011-15
Figure 2: Canada pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Canada pharmaceuticals market share: % share, by value, 2015
Figure 4: Canada pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Canada, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Canada, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Canada, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2015
Figure 11: Johnson and Johnson: revenues and profitability
Figure 12: Johnson and Johnson: assets and liabilities
Figure 13: Merck and Co., Inc.: revenues and profitability
Figure 14: Merck and Co., Inc.: assets and liabilities
Figure 15: Pfizer Inc.: revenues and profitability
Figure 16: Pfizer Inc.: assets and liabilities

COMPANIES MENTIONED

Apotex, Inc.
Johnson and Johnson
Merck and Co., Inc.
Pfizer Inc.
Skip to top


OTC Pharmaceuticals in Canada US$ 350.00 Sep, 2016 · 38 pages
Canada Pharmaceutical Industry 2016 US$ 850.00 Feb, 2016 · 160 pages

Ask Your Question

Pharmaceuticals in Canada
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: